U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Shoreside Enterprises Inc. - 422722 - 05/26/2020
  1. Warning Letters

CLOSEOUT LETTER

Shoreside Enterprises Inc. MARCS-CMS 422722 —

Delivery Method:
VIA Electronic Mail
Reference #:
20-HAFE4-WLCOL-07
Product:
Drugs
Recipient:
Recipient Name
Mr. Brian Moses
Recipient Title
President
Shoreside Enterprises Inc.

6321 Newtown Cir.
Apt B1
Tampa, FL 33615-3615
United States

Shoresideenterprises@yahoo.com
Issuing Office:
Office of Human and Animal Food Operations Division IV East

United States

(787) 729-8500

Dear Mr. Moses:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter, FLA-15-09 dated December 23, 2014. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from your responsibility of assuring that your establishment is in compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. If you have any questions, please feel free to contact Ms. Pearl Lopina, Compliance Officer at telephone number (407) 475-4730 or at e-mail address pearl.lopina@fda.hhs.gov.

Kind regards,
/S/
Edwin Ramos
Director of Compliance Branch
OHAFO, Division IV East

Back to Top